Showing all 2 results
The Estrogen Receptor + Progesterone Receptor + HER-2/neu test is a comprehensive diagnostic tool used to evaluate breast cancer tumors for the presence of three critical biomarkers: estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER-2/neu).
Sample Type : Paraffin Embedded Block/Charged Slides
Methodology : Immunohistochemical
TAT : 7 Days
The HER-2/NEU – FISH Test is a highly precise diagnostic tool used to detect HER-2 gene amplification in breast cancer and other malignancies. Utilizing Fluorescence In Situ Hybridization (FISH) technology, it provides accurate, reliable, and early detection of HER-2 status, which is crucial for determining targeted therapy eligibility, such as Herceptin (trastuzumab) treatment. This test offers higher sensitivity and specificity compared to immunohistochemistry (IHC), reducing false-positive or false-negative results. Its rapid turnaround time and clinically validated methodology make it a gold standard for personalized cancer treatment, ensuring optimal therapeutic decisions and improved patient outcomes.